HealthEquity PE Ratio 2014-2024 | HQY

Current and historical p/e ratio for HealthEquity (HQY) from 2014 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. HealthEquity PE ratio as of November 05, 2024 is 42.29.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

HealthEquity PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-05 89.23 74.36
2024-07-31 78.48 $1.20 65.40
2024-04-30 78.91 $0.92 85.77
2024-01-31 75.58 $0.64 118.09
2023-10-31 71.68 $0.34 210.82
2023-07-31 67.94 $0.15 452.93
2023-04-30 53.45 $-0.10 0.00
2023-01-31 60.85 $-0.31 0.00
2022-10-31 77.91 $-0.70 0.00
2022-07-31 58.17 $-0.74 0.00
2022-04-30 62.32 $-0.66 0.00
2022-01-31 53.44 $-0.53 0.00
2021-10-31 66.18 $-0.07 0.00
2021-07-31 73.98 $0.01 7398.00
2021-04-30 75.97 $0.06 1266.17
2021-01-31 83.55 $0.12 696.25
2020-10-31 51.49 $0.05 1029.80
2020-07-31 51.56 $-0.27 0.00
2020-04-30 56.27 $0.03 1875.67
2020-01-31 66.06 $0.65 101.63
2019-10-31 56.79 $0.86 66.03
2019-07-31 81.98 $1.41 58.14
2019-04-30 67.75 $1.47 46.09
2019-01-31 62.34 $1.18 52.83
2018-10-31 91.80 $1.06 86.60
2018-07-31 75.50 $0.98 77.04
2018-04-30 65.67 $0.89 73.79
2018-01-31 50.62 $0.76 66.61
2017-10-31 50.22 $0.74 67.86
2017-07-31 45.87 $0.67 68.46
2017-04-30 45.52 $0.54 84.30
2017-01-31 46.25 $0.45 102.78
2016-10-31 33.23 $0.43 77.28
2016-07-31 29.52 $0.40 73.80
2016-04-30 25.15 $0.34 73.97
2016-01-31 21.55 $0.29 74.31
2015-10-31 32.71 $0.26 125.81
2015-07-31 33.66 $0.24 140.25
2015-04-30 26.21 $0.23 113.96
Sector Industry Market Cap Revenue
Medical Medical Services $7.792B $1.000B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00